Africa CDC Says Ebola Funding Gap Shows Why Health Security Must Be Financed From Within

By Towncrier Editorial Desk

Africa’s latest Ebola response is exposing a familiar weakness in the continent’s health-security architecture: emergency pledges often arrive faster than usable money, while vaccine research, local production and outbreak systems remain heavily dependent on external partners.

The Africa Centres for Disease Control and Prevention has warned that the outbreak response in the Democratic Republic of Congo and Uganda needs stronger African financing, faster disbursement of pledged funds and a longer-term shift toward local vaccine and medicine production.

According to Associated Press reporting from Addis Ababa, Africa CDC Director-General Dr Jean Kaseya said African governments must invest more of their own resources in outbreak response and vaccine development, after an Ebola outbreak in Congo and Uganda claimed more than 200 lives from 894 confirmed cases since May 15. Africa CDC also said up to 35,000 contacts were being traced, with case numbers likely undercounted because confirmation came weeks late.

The financing gap is stark. Reuters, citing Africa CDC officials, reported that donors had pledged about $910 million to support the Ebola response, including $80 million from African Union member states, but less than $90 million had actually been received by the affected countries at the time of the briefing.

That difference between pledges and disbursements matters in an outbreak. Contact tracing, laboratory confirmation, treatment centres, protective equipment, public communication, cross-border surveillance and community engagement require predictable cash flows. Delayed funds weaken response speed precisely when speed matters most.

The outbreak also highlights a deeper vaccine problem. Africa CDC has repeatedly argued that the continent cannot continue to rely almost entirely on imported health products during public-health emergencies. AP reported that Africa produces less than 1 percent of the vaccines it uses and only about 3 percent of its medicines, a structural dependence exposed during COVID-19 and now again in Ebola response planning.

For Africa CDC, the lesson is not that international partners are irrelevant. It is that external support cannot remain the foundation of African health security. Emergency response needs domestic budget lines, continental pooled funds, regional manufacturing capacity, stronger procurement systems and more reliable outbreak reserves.

The current Ebola situation is especially sensitive because different Ebola strains do not carry the same vaccine-readiness profile. While vaccines exist for the Zaire strain, Africa CDC officials have pointed to gaps around the Bundibugyo strain. That makes research, manufacturing and clinical preparedness part of the financing debate, not separate technical issues.

Africa’s health-financing challenge is therefore not only about the size of pledges made at donor conferences. It is about who controls the money, how quickly funds move, whether African institutions can procure and deploy resources, and whether local production can reduce dependence before the next emergency arrives.

The African Epidemic Fund, which AP reported has secured $80 million from governments, is one attempt to build that internal base. But the scale of the current response shows how far the continent still has to go before its emergency financing matches the speed and complexity of outbreaks.

For DRC and Uganda, the immediate priority remains containment: tracing contacts, protecting health workers, isolating cases, treating patients and communicating clearly with communities. For the African Union and member states, the bigger question is whether this outbreak will accelerate a shift from donor-dependent emergency response to a continentally financed health-security model.

If the answer is no, Africa risks repeating the same cycle: emergency declaration, donor conference, delayed disbursement, operational strain and renewed calls for self-reliance after the crisis has already intensified. If the answer is yes, the Ebola response could become a turning point in how Africa funds outbreak preparedness, vaccine access and medical sovereignty.

Sources: Africa CDC statements as reported by the Associated Press and Reuters; AP interview with Africa CDC Director-General Dr Jean Kaseya; Reuters report on Africa CDC pledge and disbursement figures.